CCR5 Blocker Maraviroc Reverses Age-Driven Immune Imbalance in Mice
One of the most underappreciated drivers of accelerated aging is the slow drift of the immune system toward chronic…
One of the most underappreciated drivers of accelerated aging is the slow drift of the immune system toward chronic…
Visual hallucinations in older adults are frequently misattributed to psychiatric illness or dementia, causing…
Tuberculosis remains one of the most consequential infectious disease challenges of our era, and a sweeping new…
Stroke in a 33-year-old is rare enough to prompt scrutiny of any plausible precipitating event — and when that event…
In post-conflict societies where mental health infrastructure is sparse and trauma exposure is already elevated…
Decades of vigorous endurance training may confer a physiological paradox: the very habits that protect most people…
Understanding why breast cancer brain metastases resist immunotherapy has long frustrated oncologists. A new spatial…
Understanding why some individuals with ADHD respond poorly to standard stimulant therapy has long frustrated…
For decades, the field has known that tau aggregates kill neurons—but not precisely how. Pinpointing the molecular…
For the millions living with hearing loss, the greatest daily frustration isn't silence — it's noise. Conventional…
One of the most frustrating clinical dilemmas in modern oncology is that the same immunotherapy drugs that can shrink…
Sleep disturbances in schizophrenia are notoriously difficult to untangle from the disorder itself, its medications…
Understanding how the nervous system coordinates movement, sensation, and internal physiology has been one of…
The conventional division between norepinephrine and dopamine signaling in the brain may be less clean than textbooks…
Radiation exposure from CT imaging accumulates silently over a patient's lifetime, and emergency departments have long…
Postpartum hemorrhage remains the single largest contributor to maternal mortality worldwide, yet the clinical…
One of the most stubborn obstacles in solid-tumor immunotherapy is antigen escape — when cancer cells shed the surface…
Incretin receptor agonists — GLP-1 drugs like semaglutide — achieve striking weight loss, yet clinical discontinuation…
A phase 2 randomized controlled trial of 120 Chinese adults with overweight or obesity (no diabetes) tested…
GLP-1 receptor agonists and emerging incretin multi-agonists (dual/triple receptor agonists) exert coordinated effects…
Get daily health research summaries delivered to your inbox.
Browse our synthesized research summaries by topic. We cover the latest findings from journals like Nature Medicine, The Lancet, Cell Metabolism, and 100+ other peer-reviewed sources.